A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.

Solomon SS, Wagner-Cardoso S, Smeaton L, Smeaton L. A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. Lancet Gastroenterol Hepatol [Internet]. 2022;7(4):307-317. https://doi.org/10.1016/S2468-1253(21)00397-6

Publication Type:

Journal Article

Authors:

Solomon, SS; Wagner-Cardoso, S; Smeaton, L; et al

Source:

Lancet Gastroenterol Hepatol, Volume 7, Issue 4, p.307-317 (2022)

URL:

https://doi.org/10.1016/S2468-1253(21)00397-6

Cited On:

External Third-party Web Link:

https://pubmed.ncbi.nlm.nih.gov/35026142/

Export Citation:
RIS Format
Top